News | Cardiovascular Business | August 17, 2022

Memorial Cardiac and Vascular Institute Adds Cardiologists to its Physician Roster

Memorial Healthcare System, a South Florida-based academic medical center, has added a diverse trio of doctors to its cardiac care team. 

Adetola Ladejobi, MD

Adetola Ladejobi, MD 


August 17, 2022 — Memorial Healthcare System, a South Florida-based academic medical center, has added a diverse trio of cardiologists to its cardiac care team. The fellowship-trained physicians have all worked internationally during their medical careers and join Memorial Cardiac and Vascular Institute as it grows its research and academic programs. 

Adetola Ladejobi, MD, an electrophysiologist, comes to Memorial from the Mayo Clinic, where he completed two fellowships and was an instructor at its college of medicine. Dr. Ladejobi is focused on patient care, research, quality improvement, and healthcare operations. A native of Nigeria, “Tola” earned a master’s degree in public health from Harvard University and has also worked as a strategic consultant to healthcare systems, insurance companies, and Fortune 100 companies. 

Lynda Otalvaro, MD, a clinical cardiologist, was most recently at the University of Florida where she was an assistant professor at UF’s College of Medicine and director of its Lipid Clinic. In the time prior to that, Dr. Otalvaro worked as an adult non-invasive cardiologist in Kentucky. She finished first in her class at Universidad Libre, School of Medicine in Cali, Colombia before coming to the University of Miami’s Miller School of Medicine. While at UM, Dr. Otalvaro completed an internal medicine residency and fellowship in cardiology. 

Sarah Rosanel, MD, completed both an internal medicine residency and cardiovascular disease fellowship at Maimonides Medical Center in Brooklyn, NY. A clinical cardiologist, Dr. Rosanel earned degrees from the Israel Institute of Technology’s Technion American Medical School and Yeshiva University in New York. 

“The capabilities, accomplishments, and diverse backgrounds of these physicians will
enhance Memorial’s offerings as an academic medical center, on par with larger, university-based systems,” said Dr. Michael Cortelli, chief of the Memorial Cardiac and Vascular Institute. “Their clinical, research, and academic expertise will benefit our patients and doctors alike.” 

Memorial’s Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Physician-review panels and nurses regularly review cardiovascular care outcomes to ensure quality assurance that utilizes computerized data collection. 

With extraordinary medical expertise, advanced technology and exacting quality guidelines, Memorial Cardiac & Vascular Institute offers a superior level of cardiovascular care. 

For more information: https://www.mhs.net/ 


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now